Reproductive and hormonal risk factors for thyroid cancer in Los Angeles County females

Cancer Epidemiology Biomarkers and Prevention

Volumn 8, Issue 11, 1999, Pages 991-997

  Mack, Wendy J ^a   Preston Martin, Susan ^a   Bernstein, Leslie ^a   Qian, Dajun ^a   Xiang, Min ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN DERIVATIVE; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; BREAST FEEDING; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTROGEN THERAPY; FEMALE; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; LACTATION INHIBITION; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; MENSTRUAL IRREGULARITY; ORAL CONTRACEPTION; OVARIECTOMY; PREGNANCY; PRIORITY JOURNAL; RADIOTHERAPY; RISK ASSESSMENT; THYROID CARCINOMA; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; CALIFORNIA; CARCINOMA, PAPILLARY, FOLLICULAR; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; FEMALE; HEALTH SURVEYS; HUMANS; INCIDENCE; LOGISTIC MODELS; LOS ANGELES; MIDDLE AGED; ODDS RATIO; PREGNANCY; QUESTIONNAIRES; REFERENCE VALUES; REPRODUCTIVE HISTORY; RISK ASSESSMENT; RISK FACTORS; THYROID HORMONES; THYROID NEOPLASMS;

EID: 0032749336     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Henderson, B. E., Ross, R. K., Pike, M. C., and Casagrande, J. T. Endogenous hormones as a major factor in human cancer. Cancer Res., 42: 3232-3239, 1982.
2. Williams, E. D. TSH and thyroid cancer. Horm. Metab. Res., 23: 72-15, 1990.
3. Hegedues, L. Thyroid size determined by ultrasound. Influence of physiological factors and non-thyroidal disease. Dan. Med. Bull., 37: 249-263, 1990.
4. Glinoer, D., De Nayer, P., Bourdoux, P., Lemone, M., Robyn, C., Van Steirteghem, A., Kinthaert, J., and Lejeune, B. Regulation of maternal thyroid during pregnancy. J. Clin. Endocrinol. Metab., 71: 276-287, 1990.
5. Burrow, G. N. Thyroid function and hyperfunction during gestation. Endocr. Rev., 14: 194-202, 1993.
6. Malkasian, G. D., and Mayberry, W. E. Serum total and free thyroxine and thyrotropin in normal and pregnant women, neonates, and women receiving progestogens. Am. J. Obstet. Gynecol., 108: 1234-1238, 1970.
7. Rastogi, G. K., Sawhney, R. C., Sinha, M. K., Thomas, Z., and Devi, P. K. Serum and urinary levels of thyroid hormones in normal pregnancy. Obstet. Gynecol., 44: 176-180, 1974.
8. Kennedy, R. L., and Darne, J. The role of hCG in regulation of the thyroid gland in normal and abnormal pregnancy. Obstet. Gynecol., 78: 298-307, 1991.
9. Mann, K., and Hoermann, R. Thyroid stimulation by placental factors. J. Endocrinol. Invest., 16: 378-384, 1993.
10. McTiernan, A. M., Weiss, N. S., and Daling, J. R. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors. Am. J. Epidemiol., 120: 423-435, 1984.
11. McTiernan, A., Weiss, N. S., and Daling, J. R. Incidence of thyroid cancer in women in relation to known or suspected risk factors for breast cancer. Cancer Res., 47: 292-295, 1987.
12. Ron, E., Kleinerman, R. A., Boice, J., LiVolsi, V. A., Flannery, J. T., and Fraumeni, J. A population-based case-control study of thyroid cancer. J. Natl. Cancer Inst., 79: 1-12, 1987.
13. Preston-Martin, S., Bernstein, L., Pike, M. C., Maldonado, A. A., and Henderson, B. E. Thyroid cancer among young women related to prior thyroid disease and pregnancy history. Br. J. Cancer, 55: 191-195, 1987.
14. Kolonel, L. N., Hankin, J. H., Wilkens, L. R., Fukunaga, F. H., and Hinds, M. W. An epidemiologic study of thyroid cancer in Hawaii. Cancer Causes Control, 1: 223-234, 1990.
15. Franceschi, S., Fassina, A., Talamini, R., Mazzolini, A., Vianello, S., Bidoli, E., Cizza, G., and La Vecchia, C. The influence of reproductive and hormonal factors on thyroid cancer in women. Rev. Epidemiol. Sante Publique, 38: 27-34, 1990.
16. Kravdal, O., Glattre, E., and Haldorsen, T. Positive correlation between parity and incidence of thyroid cancer: new evidence based on complete Norwegian birth cohorts. Int. J. Cancer, 49: 831-836, 1991.
17. Akslen, L. A., Nilssen, S., and Kvale, G. Reproductive factors and risk of thyroid cancer. A prospective study of 63,090 women from Norway. Br. J. Cancer, 65: 772-774, 1992.
18. Goodman, M. T., Kolonel, L. N., and Wilkens, L. R. The association of body size, reproductive factors and thyroid cancer. Br. J. Cancer, 66: 1180-1184, 1992.
19. LaVecchia, C., Negri, E., Franceschi, S., and Parazzini, F. Long-term impact of reproductive factors on cancer risk. Int. J. Cancer, 53: 215-219, 1993.
20. Levi, F., Franceschi, S., Gulie, C., Negri, E., and LaVecchia, C. Female thyroid cancer: the role of reproductive and hormonal factors in Switzerland. Oncology (Basel), 50: 309-315, 1993.
21. Preston-Martin, S., Jin, F., Duda, M. J., and Mack, W. J. A case-control study of thyroid cancer in women under age 55 in Shanghai (People's Republic of China). Cancer Causes Control, 4: 431-440, 1993.
22. Wingren, G., Hatschek, T., and Axelson, O. Determinants of papillary cancer of the thyroid. Am. J. Epidemiol., 138: 482-491, 1993.
23. Galanti, M. R., Lambe, M., Ekbom, A., Sparen, P., and Pettersson, B. Parity and risk of thyroid cancer: a nested case-control study of a nationwide Swedish cohort. Cancer Causes Control, 6: 37-44, 1995.
24. Galanti, M. R., Hansson, L., Lund, E., Bergstrom, R., Grimelius, L., Stalsberg, H., Carlsen, E., Baron, J. A., Persson, I., and Ekbom, A. Reproductive history and cigarette smoking as risk factors for thyroid cancer in women: a population-based case-control study. Cancer Epidemiol. Biomark. Prev., 5: 425-431, 1996.
25. Takezaki, T., Hirose, K., Inoue, M., Hamajima, N., Kuroishi, T., Nakamura, S., Koshikawa, T., Matsuura, H., and Tajima, K. Risk factors of thyroid cancer among women in Tokai, Japan. J. Epidemiol., 6: 140-147, 1996.
26. Persson, I., Yuen, J., Bergkvist, L., and Schairer, C. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy-long-term follow-up of a Swedish cohort. Int. J. Cancer, 67: 327-332, 1996.
27. Rossing, M. A., Voigt, L. F., Wicklund, K. G., Williams, M., and Daling, J. R. Use of exogenous hormones and risk of papillary thyroid cancer (Washington, United States). Cancer Causes Control, 9: 341-349, 1998.
28. Negri, E., Dal Maso, L., Ron, E., La Vecchia, C., Mark, S. D., Preston-Martin, S., McTiernan, A., Kolonel, L., Yoshimoto, Y., Jin, F., Wingren, G., Galanti, M. R., Hardell, L., Glattre, E., Lund, E., Levi, F., Linos, D., Braga, C., and Franceschi, S. A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control, 10: 143-155, 1999.
29. La Vecchia, C., Ron, E., Franceschi, S., Dal Maso, L., Mark, S. D., Chatenoud, L., Braga, C., Preston-Martin, S., McTiernan, A., Kolonel, L., Mabuchi, K., Jin, F., Wingren, G., Galanti, M. R., Hallquist, A., Lund, E., Levi, F., Linos, D., and Negri, E. A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control, 10: 157-166, 1999.
30. Preston-Martin, S., Pike, M. C., Ross, R. K., Jones, P. A., and Henderson, B. E. Increased cell division as a cause of human cancer. Cancer Res., 50: 7415-7421, 1990.
31. McTiernan, A. M., Weiss, N. S., and Daling, J. R. Incidence of thyroid cancer in women in relation to previous exposure to radiation therapy and history of thyroid disease. J. Natl. Cancer Inst., 73: 575-581, 1984.
32. Levi, F., Franceschi, S., LaVecchia, C., Negri, E., Gulie, C., Duruz, G., and Scazziga, B. Previous thyroid disease and risk of thyroid cancer in Switzerland. Eur. J. Cancer, 27: 85-88, 1991.
33. Franceschi, S., Fassina, A., Talamini, R., Mazzolini, A., Vianello, S., Bidoli, E., Serraino, D., and La Vecchia, C. Risk factors for thyroid cancer in Northern Italy. Int. J. Epidemiol., 18: 578-584, 1989.
34. Paoff, K., Preston-Martin, S., Mack, W. J., and Monroe, K. A case-control study of maternal risk factors for thyroid cancer in young women (California, United States). Cancer Causes Control, 6: 389-397, 1995.
35. Chiovato, L., Lapi, P., Fiore, E., Tonacchera, M., and Pinchera, A. Thyroid autoimmunity and female gender. J. Endocrinol. Invest., 16: 384-391, 1993.
36. Glinoer, D., Soto, M. F., Bourdoux, P., Lejeune, B., Delange, F., Lemone, M., Kinthaert, J., Robijn, C., Grun, J-P., and De Nayer, P. Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. J. Clin. Endocrinol. Metab., 73: 421-427, 1991.
37. Kochenour, N. K. Lactation suppression. Clin. Obstet. Gynecol., 23: 1045-1059, 1980.
38. Lev-Gur, M., Rodriguez, L. J., Smith, K. D., and Steinberger, E. Serum hormone changes in parturients given steroid preparations to suppress lactation. Int. J. Fertil., 35: 95-99, 1990.
39. Laube, D. Induction of labor. Clin. Obstet. Gynecol., 40: 485-495, 1997.
40. Parkin, D. M., Muir, C. S., Whelan, S. L., Gao, Y. T., Ferlay, J., and Powell, J. (eds.), Cancer Incidence in Five Continents, Vol. VI. Lyon, France: IARC, 1992.